Skip to main content
Log in

Incidence and histological features of bone marrow involvement in malignant lymphomas

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Summary

Bone marrow biopsy (BMB) is a routine investigation in the diagnosis and staging of Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL), and there is evidence supporting its prognostic importance in some histological varieties. The histological characteristics of BMB in 433 NHL and 155 HD patients were reviewed for clinicopathological correlations; 36 of these cases were also studied by means of immunohistochemistry. BM infiltrates were discovered in 171 NHL patients. In 36 cases, the diagnosis of NHL was directly established by BMB; a discordance between lymph node and BM histology was observed in 38 of the other 135 cases. BM-positive centroblastic and immunoblastic NHL were significantly associated with larger infiltrates, BM fibrosis, and megakaryocytic hyperplasia. Leukemization at diagnosis was more frequent in low-malignancy NHL. No correlation was found between histology and prognosis, although immunohistochemistry revealed a B-cell phenotype in all but two cases. BMB was positive in 18 of the 155 HD patients and directly diagnostic in two; Reed-Sternberg and Hodgkin cells were CD-30 positive and surrounded by T-cell infiltration. The concordance between BM and lymph node histology was fairly satisfactory, although the relationships between BM infiltration and other histological parameters may reflect peculiar interactions with BM microenvironmental factors. The usefulness of BMB in the diagnosis of malignant lymphomas has been demonstrated, and further progress can be expected from the availability of reliable immunohistochemical markers of clonality reacting on paraffin-embedded BM sections.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Bartl R, Frisch B, Burkhardt R, Huhn D, Pappenberger R (1982) Assessment of bone marrow histology in Hodgkin's disease: correlation with clinical factors. Br J Haematol 51: 345–360

    PubMed  Google Scholar 

  2. Bartl R, Frisch B, Burkhardt R, Kettner G, Mahl G, Fateh-Moghadam A, Sund M (1982) Assessment of bone marrow histology in the malignant lymphomas (non-Hodgkin's): correlation with clinical factors for diagnosis, prognosis, classification and staging. Br J Haematol 51: 511–530

    PubMed  Google Scholar 

  3. Bartl R, Frisch B, Burkhardt R, Jaeger K, Pappenberger R, Hoffmann-Fezer G (1984) Lymphoproliferations in the bone marrow: identification and evolution, classification and staging. J Clin Pathol 37: 233–254

    PubMed  Google Scholar 

  4. Bartl R, Hansmann ML, Frisch B, Burkhardt R (1988) Comparative histology of malignant lymphomas in lymph node and bone marrow. Br J Haematol 69: 229–237

    PubMed  Google Scholar 

  5. Bennett JM, Cain KC, Glick JH, Johnson GJ, Ezdinli E, O'Connell MJ (1986) The significance of bone marrow involvement in non-Hodgkin's lymphoma: the Eastern Cooperative Oncology Group experience. J Clin Oncol 4: 1462–1469

    PubMed  Google Scholar 

  6. Berti E, Aversa G, Soligo D, Cattoretti G, Delia D, Aiello A, Parravicini C, Hall BM, Caputo R (1991) A6: A new 45RO monoclonal antibody for immunostaining of paraffin-embedded tissues. Am J Clin Pathol 95: 188–193

    PubMed  Google Scholar 

  7. Burkhardt R, Frisch B, Bartl R (1982) Bone biopsy in haematological disorders. J Clin Pathol 35: 257–284

    PubMed  Google Scholar 

  8. Cimino G, Anselmo AP, De Luca AM, Fidani P, Mauro F, Marzullo A, Maurizi Enrici R, Papa G (1983) Bone marrow involvement at the onset of Hodgkin's disease. Tumori 69: 47–51

    PubMed  Google Scholar 

  9. Conlan MG, Bast M, Armitage JO, Weisenburger DD (1990) Bone marrow involvement by non-Hodgkin's lymphoma: the clinical significance of morphologic discordance between the lymph node and bone marrow. J Clin Oncol 8: 1163–1172

    PubMed  Google Scholar 

  10. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219–229

    PubMed  Google Scholar 

  11. Dalchau R, Flanagan BF, Fabre JW (1986) Structural implications of the location and stability to proteolytic enzymes of immunodominant determinants of the human leukocyte common molecule. Eur J Immunol 16: 993–999

    PubMed  Google Scholar 

  12. Ellis ME, Diehl LF, Granger E, Elson E (1989) Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: sensitivity and specificity of the Ann Arbor staging procedure criteria. Am J Hematol 30: 115–120

    PubMed  Google Scholar 

  13. Foucar K, McKenna RW, Frizzera G, Brunning RD (1982) Bone marrow and blood involvement by lymphoma in relationship to the Lukes-Collins classification. Cancer 49: 888–897

    PubMed  Google Scholar 

  14. Horny HP, Engst U, Walz RS, Kaiserling E (1989) In situ immunophenotyping of lymphocytes in human bone marrow: an immunohistochemical study. Br J Haematol 71: 313–321

    PubMed  Google Scholar 

  15. Jagannath S, Velasquez WS, Tucker SL, etal. (1985) Stage IV diffuse large-cell lymphoma: a long-term analysis. J Clin Oncol 3: 39–47

    PubMed  Google Scholar 

  16. Kluin PM, van Krieken JH, Kleiverda K, Kluin-Nelemans HC (1990) Discordant morphologic characteristics of B-cell lymphomas in bone marrow and lymph node biopsies. Am J Clin Pathol 94: 59–66

    PubMed  Google Scholar 

  17. Lennert K, Mohri N, Stein H, Kaiserling E (1975) The histopathology of malignant lymphoma. Br J Haematol 31 [Suppl]: 193–203

    PubMed  Google Scholar 

  18. Parwaresch MR, Radzun HJ, Kreipe H, Hansmann ML, Barth EJ (1986) Monocyte-macrophage reactive monoclonal antibody Kim6 recognizes an intracytoplasmatic antigen. Am J Pathol 125: 141–151

    PubMed  Google Scholar 

  19. Pileri S, Falini B, Sabattini E, Bigerna B, Gherlinzoni F, Tazzari PL (1991) Immunohistochemistry of malignant lymphomas. Advantages and limitations of the new monoclonal antibodies working in paraffin sections. Haematologica (Pavia) 76: 226–234

    Google Scholar 

  20. Schwarting R, Gesdes J, Durkop H, Falini B, Pileri S, Stein H (1989) BerH2: a new anti Ki-1 (CD30) monoclonal antibody directed at a formol-resistant epitope. Blood 74: 1678–1689

    PubMed  Google Scholar 

  21. Siegelman MH, Cleary ML, Warnke R, Sklar J (1985) Frequent biclonality and Ig gene alterations among B-cell lymphomas that show multiple histologic forms. J Exp Med 161: 850–863

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lambertenghi-Deliliers, G., Annaloro, C., Soligo, D. et al. Incidence and histological features of bone marrow involvement in malignant lymphomas. Ann Hematol 65, 61–65 (1992). https://doi.org/10.1007/BF01698130

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01698130

Key words

Navigation